Clinical Trial Update: The Study of The Treatment of Postoperative Adjuvant Apatinib vs. TACE in Hepatocellular Carcinoma Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing postoperative adjuvant apatinib to transarterial chemoembolization in hepatocellular carcinoma patients. Status is currently un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Guangxi Medical University | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN